Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study

• Hoofdauteurs: David Vizcaya (Auteur), Csaba P Kovesdy (Auteur), Andres Reyes (Auteur), Elena Pessina (Auteur), Pau Pujol (Auteur), Glen James (Auteur), Nikolaus G Oberprieler (Auteur)
• Formaat: Boek
• Gepubliceerd in: Becaris Publishing Limited, 2023-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Aim: Finerenone is safe and efficacious for treating patients with chronic kidney disease (CKD) and Type 2 diabetes (T2D). Evidence on the use of finerenone in clinical practice is lacking. Objective: To describe demographic and clinical characteristics of early adopters of finerenone in the United...